FDA Approves Rasonque as Pancreatic Cancer Treatment
WASHINGTON, D.C. — The Food and Drug Administration approved Revolution Medicines Inc.’s Rasonque for certain adults with metastatic pancreatic adenocarcinoma after a clinical trial showed the drug nearly doubled median …
FDA Approves Rasonque as Pancreatic Cancer Treatment Read More